Research progress on the role of common vitamins and elements in the treatment of Alzheimer's disease
Affiliation:

Zigong Institute of Brain Science

  • Article
  • | |
  • Metrics
  • |
  • Reference [65]
  • | | | |
  • Comments
    Abstract:

    Alzheimer"s disease (AD) is a neurodegenerative disease caused by a variety of risk factors, which is the main cause of dementia in the old people. At present, the pathogenesis of AD has not been studied clearly, and the treatment of AD is very limited. Clinical drugs can only alleviate the symptoms of AD to a certain extent, but can not delay the course of AD. At present, the pathogenesis of AD has not been studied clearly, and the treatment of AD is very limited. Clinical drugs can only alleviate the symptoms of AD to a certain extent, but can not delay the course of AD. A large number of studies have shown that a variety of micronutrients play a positive role in the treatment of AD. Vitamins, trace metal elements, unsaturated fatty acids and polyphenols have many functions such as anti-inflammation, anti-oxidation and protection of mitochondria. Micronutrients can effectively reduce Aβ protein plaque deposition and Tau protein hyperphosphorylation to improve brain energy metabolism, thereby achieving the prevention and treatment of AD. The purpose of this article is to explore the mechanism of micronutrients in the treatment of AD, and to review its application and effect in the treatment of AD, and to provide theoretical basis and new strategies for micronutrient intervention in the treatment of AD.

    Reference
    [1] Balakrishnan R, Jannat K, Choi DK. Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer''s disease [J]. Redox Biol, 2024, 71: 103105.
    [2] Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer''s disease in the era of biomarkers [J]. Lancet Neurol, 2021; 20(3): 222-234.
    [3] Li J, Haj Ebrahimi A, Ali AB. Advances in therapeutics to alleviate cognitive decline and neuropsychiatric symptoms of Alzheimer''s disease [J]. Int J Mol Sci, 2024, 25(10): 5169.
    [4] Chu CQ, Yu LL, Qi GY, et al. Can dietary patterns prevent cognitive impairment and reduce Alzheimer''s disease risk: exploring the underlying mechanisms of effects [J]. Neurosci Biobehav Rev, 2022, 135: 104556.
    [5] Lewis JE, Poles J, Shaw DP, et al. The effects of twenty-one nutrients and phytonutrients on cognitive function: a narrative review [J]. J Clin Transl Res, 2021; 7(4): 575-620.
    [6] Stefaniak O, Dobrzyńska M, Drzyma?a-Czy? S, et al. Diet in the prevention of Alzheimer''s disease: current knowledge and future research requirements [J]. Nutrients, 2022; 14(21): 4564.
    [7] Lee CY, Chan L, Hu CJ, et al. Role of vitamin B12 and folic acid in treatment of Alzheimer''s disease: a meta-analysis of randomized control trials [J]. Aging (Albany NY), 2024, 16(9): 7856-7869.
    [8] Xu M, Zhu Y, Chen J, et al. Effects of folic acid supplementation on cognitive impairment: a meta-analysis of randomized controlled trials [J]. J Evid Based Med, 2024, 17(1): 134-144.
    [9] Ju DT, Huang RS, Tsai BC, et al. Folic acid and folinic acid protect hearts of aging triple-transgenic Alzheimer''s disease mice via IGF1R/PI3K/AKT and SIRT1/AMPK pathways [J]. Neurotox Res, 2023, 41(6): 648-659.
    [10] Bai R, Guo J, Ye XY, et al. Oxidative stress: the core pathogenesis and mechanism of Alzheimer''s disease [J]. Ageing Res Rev, 2022, 77: 101619.
    [11] Monacelli F, Acquarone E, Giannotti C, et al. Vitamin C, aging and Alzheimer''s disease [J]. Nutrients,2017, 9(7): 670.
    [12] Bowman GL, Dodge H, Frei B, et al.Ascorbic acid and rates of cognitive decline in Alzheimer''s disease [J]. J Alzheimers Dis, 2009, 16(1): 93-98.
    [13] Huang J, May JM. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid [J]. Brain Res, 2006, 1097(1): 52-58.
    [14] Olajide OJ, Yawson EO, Gbadamosi IT, et al. Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer''s disease [J]. Environ Toxicol Pharmacol, 2017, 50: 200-211.
    [15] Kook SY, Lee KM, Kim Y, et al. High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice [J]. Cell Death Dis, 2014. 5(2): e1083.
    [16] Semwal BC, Singh B, Murti Y, et al. Therapeutic potential of ascorbic acid in the management of Alzheimer''s disease: an update [J]. Curr Pharm Biotechnol, 2023, 8: 4.
    [17] Sim M, Hong S, Jung S, et al. Vitamin C supplementation promotes mental vitality in healthy young adults: results from a cross-sectional analysis and a randomized, double-blind, placebo-controlled trial [J]. Eur J Nutr, 2022, 61(1): 447-459.
    [18] Wang W, Li Y, Meng X. Vitamin D and neurodegenerative diseases[J]. Heliyon, 2023; 9(1): e12877.
    [19] Lai RH, Hsu CC, Yu BH, et al. Vitamin D supplementation worsens Alzheimer''s progression: Animal model and human cohort studies [J]. Aging Cell, 2022, 21(8): e13670.
    [20] Ghahremani M, Smith EE, Chen HY, et al. Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status [J]. Alzheimers Dement (Amst), 2023, 15(1): e12404.
    [21] Chen LJ, Sha S, Stocker H, et al. The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer''s disease, and vascular dementia: a UK Biobank based prospective cohort study [J]. Am J Clin Nutr, 2024, 119(4): 1052-1064.
    [22] Morello M, Landel V, Lacassagne E, et al. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer''s disease [J]. Mol Neurobiol, 2018, 55(8): 6463-6479.
    [23] Saad El-Din S, Rashed L, Medhat E, et al. Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer''s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways [J]. Steroids. 2020; 156: 108586.
    [24] Ekeuku SO, Mohd Murshid N, Shukri SN, et al. Effect of Vitamin E on transcriptomic alterations in Alzheimer''s disease[J]. Int J Mol Sci, 2023; 24(15): 12372.
    [25] Nishida Y, Ito S, Ohtsuki S, et al. Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease[J]. J Biol Chem, 2009, 284(48): 33400-33408.
    [26] Mehrabadi S, Sadr SS. Administration of Vitamin D3 and E supplements reduces neuronal loss? and oxidative stress in a model of rats with Alzheimer''s disease[J]. Neurol Res, 2020, 42(10): 862-868.
    [27] Bian Z, Yu H, Hu X, et al. Tocovid attenuated oxidative stress and cognitive decline by inhibiting amyloid-β-induced NOX2 activation in Alzheimer''s disease mice [J]. J Alzheimers Dis, 2024, 99(s1): S23-S33.
    [28] Boccardi V, Poli G, Cecchetti R, et al. miRNAs and Alzheimer''s disease: exploring the role of inflammation and Vitamin E in an old-age population [J]. Nutrients, 2023, 15(3): 634.
    [29] Paganini-Hill A, Bukhari S, Montine TJ, et al. Alzheimer''s disease neuropathologic change and Vitamin supplement use decades earlier: the 90+ study [J]. Alzheimer Dis Assoc Disord, 2023, 37(1): 1-6.
    [30] Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study [J]. JAMA, 2002, 287(24): 3230-3237.
    [31] Ding H, Reiss AB, Pinkhasov A, et al. Plants, plants, and more plants: plant-derived nutrients and their protective roles in cognitive function, Alzheimer''s disease, and other dementias [J]. Medicina (Kaunas), 2022, 58(8): 1025.
    [32] Diachenko AI, Rodin IA, Krasnova TN, et al. The role of Vitamin K in the development of neurodegenerative diseases [J]. Biochemistry (Mosc), 2024, 89(Suppl 1): S57-S70.
    [33] Yagami T, Ueda K, Asakura K, et al. Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis [J]. Neuropharmacology, 2002, 43(8): 1289-1296.
    [34] Tang J, Jin Y, Jia F, et al. Gas6 promotes microglia efferocytosis and suppresses inflammation through activating Axl/Rac1 signaling in subarachnoid hemorrhage mice [J]. Transl Stroke Res, 2023, 14(6): 955-969.
    [35] Popescu A, German M. Vitamin K2 holds promise for Alzheimer''s prevention and treatment [J]. Nutrients, 2021, 13(7): 2206.
    [36] Wang B, Fang T, Chen H. Zinc and central nervous system disorders[J]. Nutrients, 2023, 15(9): 2140.
    [37] Tian ZY, Wang CY, Wang T, et al. Glial S100A6 degrades β-amyloid aggregation through targeting competition with zinc ions [J]. Aging Dis, 2019, 10(4): 756-69.
    [38] Shippy DC, Oliai SF, Ulland TK. Zinc utilization by microglia in Alzheimer''s disease [J]. J Biol Chem, 2024, 300(5): 107306.
    [39] Wang B, Fang T, Chen H. Zinc and central nervous system disorders [J]. Nutrients, 2023, 15(9): 2140.
    [40] Dong W, Gong F, Zhao Y, et al. Ferroptosis and mitochondrial dysfunction in acute central nervous system injury [J]. Front Cell Neurosci, 2023, 17: 1228968.
    [41] Peng Y, Chang X, Lang M. Iron homeostasis disorder and Alzheimer''s disease [J]. Int J Mol Sci, 2021, 22(22): 12442.
    [42] Kozlov S, Afonin A, Evsyukov I, et al. Alzheimer''s disease: as it was in the beginning [J]. Rev Neurosci, 2017, 28(8): 825-843.
    [43] Kwan P, Ho A, Baum L. Effects of deferasirox in Alzheimer''s disease and tauopathy animal models [J]. Biomolecules, 2022, 12(3): 365.
    [44] An Y, Li S, Huang X, et al. The role of copper homeostasis in brain disease [J]. Int J Mol Sci, 2022, 23(22): 13850.
    [45] Lei P, Ayton S, Bush AI. The essential elements of Alzheimer''s disease [J]. J Biol Chem, 2021, 296: 100105.
    [46] Wang Z, Zhang YH, Zhang W, et al. Copper chelators promote nonamyloidogenic processing of AβPP via MT1/2 /CREB-dependent signaling pathways in AβPP/PS1 transgenic mice [J]. J Pineal Res, 2018, 65(3): e12502.
    [47] Sun F, Zhao J, Zhang H, et al. Proteomics evidence of the role of TDMQ20 in the cholinergic system and synaptic transmission in a mouse model of Alzheimer''s disease [J]. ACS Chem Neurosci, 2022, 13(21): 3093-3107.
    [48] Kessler H, Bayer TA, Bach D, et al. Intake of copper has no effect on cognition in patients with mild Alzheimer''s disease: a pilot phase 2 clinical trial [J]. J Neural Transm (Vienna), 2008, 115(8): 1181-1187.
    [49] Welty FK. Omega-3 fatty acids and cognitive function [J]. Curr Opin Lipidol, 2023, 34(1): 12-21.
    [50] Lo Van A, Bernoud-Hubac N, Lagarde M. Esterification of docosahexaenoic acid enhances its transport to the brain and its potential therapeutic use in brain diseases [J]. Nutrients, 2022, 14(21): 4550.
    [51] Wood AHR, Chappell HF, Zulyniak MA. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer''s disease [J]. Eur J Nutr, 2022, 61(2): 589-604.
    [52] Liu Y, Liu F, Iqbal K, et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease [J]. FEBS Lett, 2008, 582(2): 359-364.
    [53] Wang Q, Huang X, Su Y, et al. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer''s disease [J]. Brain, 2022, 145(12): 4474-4488.
    [54] Patrick RP. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer''s disease [J]. FASEB J, 2019, 33(2): 1554-1564.
    [55] Gomes R, Mendes I, Duarte MP, et al. New forms of neuroactive phospholipids for DHA enrichment in brain [J]. Mar Drugs, 2024, 22(3): 116.
    [56] Huang J, Huang N, Mao Q, et al. Natural bioactive compounds in Alzheimer''s disease: From the perspective of type 3 diabetes mellitus [J]. Front Aging Neurosci, 2023, 15: 1130253.
    [57] Impellizzeri D, Tomasello M, Cordaro M, et al. MemophenolTM prevents amyloid-β deposition and attenuates inflammation and oxidative stress in the brain of an Alzheimer''s disease rat [J]. Int J Mol Sci, 2023, 24(8): 6938.
    [58] Ho L, Ferruzzi MG, Janle EM, et al. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer''s disease [J]. FASEB J, 2013, 27(2): 769-781.
    [59] Porquet D, Casadesús G, Bayod S, et al. Dietary resveratrol prevents Alzheimer''s markers and increases life span in SAMP8 [J]. Age (Dordr), 2013, 35(5): 1851-1865.
    [60] Lin YT, Wu YC, Sun GC, et al. Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer''s disease ? [J]. J Clin Med, 2018, 7(10): 329.
    [61] Chen X, Drew J, Berney W, et al. Neuroprotective natural products for Alzheimer''s disease [J]. Cells, 2021, 10(6): 1309.
    [62] Garcia-Alloza M, Borrelli LA, Rozkalne A, et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model [J]. J Neurochem, 2007, 102(4): 1095-1104.
    [63] Sahiner M, Yilmaz AS, Gungor B, et al. A review on phyto-therapeutic approaches in Alzheimer''s disease [J]. J Funct Biomater, 2023, 14(1): 50.
    [64] Wang H, Wang H, Cheng H, et al. Ameliorating effect of luteolin on memory impairment in an Alzheimer''s disease model [J]. Mol Med Rep, 2016, 13(5): 4215-4220.
    [65] Ali F, Rahul, Jyoti S, Naz F, et al. Therapeutic potential of luteolin in transgenic drosophila model of Alzheimer''s disease [J]. Neurosci Lett, 2019, 692: 90-99.
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:69
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:June 07,2024
  • Revised:January 10,2025
  • Adopted:February 18,2025
Article QR Code